These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16039276)

  • 21. Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and MCP-1.
    Joner M; Farb A; Cheng Q; Finn AV; Acampado E; Burke AP; Skorija K; Creighton W; Kolodgie FD; Gold HK; Virmani R
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):182-9. PubMed ID: 17068283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-density lipoprotein apolipoprotein A-I kinetics: comparison of radioactive and stable isotope studies.
    Ooi EM; Watts GF; Farvid MS; Chan DC; Allen MC; Zilko SR; Barrett PH
    Eur J Clin Invest; 2006 Sep; 36(9):626-32. PubMed ID: 16919045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.
    Pászty C; Maeda N; Verstuyft J; Rubin EM
    J Clin Invest; 1994 Aug; 94(2):899-903. PubMed ID: 8040345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein AI levels are increased in part as a consequence of reduced catabolism in nephrotic rats.
    Kaysen GA; Hoye E; Jones H
    Am J Physiol; 1995 Mar; 268(3 Pt 2):F532-40. PubMed ID: 7900854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New model for kinetic studies of HDL metabolism in humans.
    Chétiveaux M; Ouguerram K; Zair Y; Maugère P; Falconi I; Nazih H; Krempf M
    Eur J Clin Invest; 2004 Apr; 34(4):262-7. PubMed ID: 15086357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pioglitazone protects HDL(2&3) against oxidation in overweight and obese men.
    McEneny J; McPherson PA; McGinty A; Hull SS; McCance DR; Young IS
    Ann Clin Biochem; 2013 Jan; 50(Pt 1):20-4. PubMed ID: 23148280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palmitic acid in HDL is associated to low apo A-I fractional catabolic rates in vivo.
    Pérez-Méndez O; Alvarez-Salcedo P; Carreón Torres E; Luc G; Arce Fonseca M; de la Peña A; Cruz Robles D; García JJ; Vargas-Alarcón G
    Clin Chim Acta; 2007 Mar; 378(1-2):53-8. PubMed ID: 17173884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat.
    Staels B; Van Tol A; Fruchart JC; Auwerx J
    Isr J Med Sci; 1996 Jun; 32(6):490-8. PubMed ID: 8682657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of pioglitazone on nitric oxide bioavailability measured using a catheter-type nitric oxide sensor in angiotensin II-infusion rabbit.
    Imanishi T; Kuroi A; Ikejima H; Kobayashi K; Mochizuki S; Goto M; Yoshida K; Akasaka T
    Hypertens Res; 2008 Jan; 31(1):117-25. PubMed ID: 18360026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic hyperinsulinemia does not increase the production rate of high-density lipoprotein apolipoprotein AI: evidence from a kinetic study in patients with insulinoma.
    Duvillard L; Florentin E; Pont F; Petit JM; Baillot-Rudoni S; Penfornis A; Vergès B
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2460-5. PubMed ID: 23908245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.
    Holvoet P; Danloy S; Deridder E; Lox M; Bernar H; Dhoest A; Collen D
    J Clin Invest; 1998 Jul; 102(2):379-85. PubMed ID: 9664079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo conversion of recombinant human proapolipoprotein AI (rh-Met-proapo AI) to apolipoprotein AI in rabbits.
    Saku K; Liu R; Ohkubo K; Bai H; Hirata K; Yamamoto K; Morimoto Y; Yamada K; Arakawa K
    Biochim Biophys Acta; 1993 Apr; 1167(3):257-63. PubMed ID: 8481386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pioglitazone reduces tumor necrosis factor-alpha serum concentration and mRNA expression of adipose tissue in hypercholesterolemic rabbits.
    Wu ZH; Zhao SP; Chu LX; Ye HJ
    Int J Cardiol; 2010 Jan; 138(2):151-6. PubMed ID: 18809217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of induced atherosclerosis in h-apo AI transgenic mice by overexpression of human apo AI in the aortic wall.
    Li H; Gu S; Cao X; Wang Z; She M
    Chin Med J (Engl); 2000 Jul; 113(7):657-61. PubMed ID: 11776042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between apolipoprotein C-III concentrations and high-density lipoprotein subclass distribution.
    Tian L; Wu J; Fu M; Xu Y; Jia L
    Metabolism; 2009 May; 58(5):668-74. PubMed ID: 19375590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compositional changes and apoprotein A-I metabolism of plasma high density lipoprotein in estrogenized chicks.
    Cho BH; Park JR
    Lipids; 1991 Oct; 26(10):819-23. PubMed ID: 1795603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of expressed human apolipoprotein AI on plasma high density lipoprotein level in transgenic mice].
    Li H; Gu S; She M
    Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):531-3. PubMed ID: 10923465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein AI and apolipoprotein E mRNA expression in peripheral white blood cells from patients with orthotopic liver transplantation.
    Martínez-López E; Nuño-González P; Ruiz-Madrigal B; Rodríguez-Sancho LC; Hernández-Nazará ZH; Segura-Ortega JE; Panduro A
    Liver Int; 2007 Sep; 27(7):930-7. PubMed ID: 17696931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo kinetics of human apolipoprotein A-I variants in rabbits.
    Saku K; von Eckardstein A; Zhang B; Liu R; Jimi S; Ou J; Ohta T; Assmann G; Arakawa K
    Eur J Clin Invest; 1999 Mar; 29(3):196-203. PubMed ID: 10202375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.